Looks like you may have picked a good entry point Resurgam. The share price certainly seems be under the control of some big players so who knows how it will play out in the lead up to trial results. Interesting times ahead given the company has given no indication as to how it will proceed if trial results are positive. I suppose the options are licence out the OPT-302, raise funds for phase III trials or there is the possibity the company will get taken over. I suppose it all depends on the data and share price.
Ann: Change of Director's Interest Notice - MS, page-5
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.005(1.33%) |
Mkt cap ! $492.4M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 40.0¢ | 37.5¢ | $1.125M | 2.903M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 127806 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.5¢ | 49437 | 5 |
View Market Depth
| Last trade - 14.48pm 18/07/2024 (20 minute delay) ? |
| OPT (ASX) Chart |